Explore the words cloud of the BRIGHTER project. It provides you a very rough idea of what is the project "BRIGHTER" about.
The following table provides information about the project.
FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
|Coordinator Country||Spain [ES]|
|Total cost||3˙520˙720 €|
|EC max contribution||3˙459˙052 € (98%)|
1. H2020-EU.1.2.1. (FET Open)
|Duration (year-month-day)||from 2019-07-01 to 2022-06-30|
Take a look of project's partnership.
|1||FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA||ES (BARCELONA)||coordinator||750˙106.00|
|2||MYCRONIC AB||SE (TABY)||participant||945˙960.00|
|3||JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN||DE (FRANKFURT AM MAIN)||participant||704˙346.00|
|4||TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY||IL (HAIFA)||participant||588˙015.00|
|5||CELLENDES GMBH||DE (REUTLINGEN)||participant||470˙625.00|
Engineered tissues are key elements in both in vitro and in vivo applications, strongly impacting the academy, pharma and clinical sectors. Bioprinting is considered the most promising method to produce such engineered tissues. However, current bioprinting methods are severely limited by both insufficient speed and spatial resolution. Long printing times decrease cell viability, while poor spatial resolution fails to recreate the heterogeneous nature of native tissues. BRIGHTER will develop a new bioprinting technology able to produce tissue surrogates with high spatial resolution at high printing speed using an original top-down lithography approach, in contrast with current bottom-up, layer-by-layer bioprinting methods. BRIGHTER will combine high-speed light-sheet illumination and high-resolution digital photomasks to selectively photocrosslink cell-laden hydrogels in confined voxels and produce three-dimensional complex geometries. This process will enable the bioprinting of key anatomical microfeatures of tissue such as invaginations, evaginations or wavy morphologies. It will also incorporate hollow vascular structures while maintaining tissue mechanical integrity without the need of additional sacrificial material. As a remarkable feature, matrix crosslinking density can be fine-tuned using BRIGHTER’s approach, allowing the fabrication of cellular compartments requiring specific matrix stiffness such as stem cell niches. The proof-of-concept application will be bioprinting viable engineered skin tissues exploiting the key features of the BRIGHTER device: skin appendix (hair follicles, sweat glands), stem cell niches and a vascular network. The ultimate goal is to provide a superior alternative to state-or-the art 3D bioprinting with a disruptive bioprinting technology that would create new scientific and business opportunities.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BRIGHTER" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "BRIGHTER" are provided by the European Opendata Portal: CORDIS opendata.